Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
Gyeoung-Jin Kang, Eun Ji Kim, Chang Hoon Lee
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1259-1259
Open Access | Times Cited: 21

Showing 21 citing articles:

Short-chain fatty acids as modulators of redox signaling in health and disease
Carmen González‐Bosch, Emily Boorman, Patricia A. Zunszain, et al.
Redox Biology (2021) Vol. 47, pp. 102165-102165
Open Access | Times Cited: 155
Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction
Yixuan Ma, Yixin Kuang, Wenyan Bo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12341-12341
Open Access | Times Cited: 85
PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling
Francesca Oppedisano, Rocco Mollace, Annamaria Tavernese, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 2965-2965
Open Access | Times Cited: 37
Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches
Wenlong Hao, Minghao Li, Qingmin Cai, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 16
Cardiac macrophage metabolism in health and disease
Benjamin J. Kopecky, Kory J. Lavine
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 3, pp. 249-262
Open Access | Times Cited: 9
Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases
Roddy Hiram
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 5179-5197
Open Access | Times Cited: 15
Aspirin-Triggered Resolvin D1 (AT-RvD1) Protects Mouse Skin against UVB-Induced Inflammation and Oxidative Stress
Cristina P. B. Melo, Priscila Saito, Renata M. Martínez, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2417-2417
Open Access | Times Cited: 8
Lipoprotection in cardiovascular diseases
Marcel Benkhoff, Amin Polzin
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108747-108747
Closed Access | Times Cited: 2
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
Juan Salazar, Daniela Pírela, Manuel Nava, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3133-3133
Open Access | Times Cited: 12
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
Almudena Val‐Blasco, Patricia Prieto, Rafael I. Jaén, et al.
JACC Basic to Translational Science (2022) Vol. 7, Iss. 6, pp. 544-560
Open Access | Times Cited: 11
Involvement of ischemia-driven 5-lipoxygenase-resolvin-E1-chemokine like receptor-1 axis in the resolution of post-coronary artery bypass graft inflammation in coronary arteries
Finosh G. Thankam, Victoria Wilson, Mohamed M. Radwan, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 4, pp. 3123-3134
Closed Access | Times Cited: 10
Eicosapentaenoic Acid Ameliorates Cardiac Fibrosis and Tissue Inflammation in Spontaneously Hypertensive Rats
Nazli Gharraee, Zhan Wang, Adam Pflum, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 11, pp. 100292-100292
Open Access | Times Cited: 10
Clinical significance of polyunsaturated fatty acids in the prevention of cardiovascular diseases
Stanislav Kotlyarov, Anna Kotlyarova
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 9
Mouse models of nonalcoholic steatohepatitis and their application to new drug development
Huy Hieu Phung, Chang Hoon Lee
Archives of Pharmacal Research (2022) Vol. 45, Iss. 11, pp. 761-794
Closed Access | Times Cited: 9
Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
Andrea Gila-Díaz, Gloria Herranz Carrillo, Pratibha Singh, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 933-933
Open Access | Times Cited: 12
The Association of Metabolomic Profiles of a Healthy Lifestyle with Heart Failure Risk in a Prospective Study
Yuanyuan Ma, M I N G Chu, Zuqiang Fu, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2934-2934
Open Access | Times Cited: 4
Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
Subhapradha Rangarajan, Davit Orujyan, Patrida Rangchaikul, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2829-2829
Open Access | Times Cited: 7
Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
Kenneth T. Bogen
Environmental Research (2023) Vol. 230, pp. 115047-115047
Open Access | Times Cited: 2
Natural Antioxidant in Cardiovascular and Cerebrovascular Diseases
Yi‐Sook Jung
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1159-1159
Open Access | Times Cited: 3
Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review
Cristian Sandoval, Karen Nahuelqueo, Luciana Mella, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access
Ultrasensitive Dose-Response for Asbestos Cancer Risk Implied by New Inflammation-Mutation Model
Kenneth T. Bogen
SSRN Electronic Journal (2022)
Closed Access
Page 1

Scroll to top